1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Utah >
  6. Genta Acquires Salus Therapeutics

M&A Deal Summary

Genta Acquires Salus Therapeutics

On August 25, 2003, Genta acquired life science company Salus Therapeutics

Acquisition Highlights
  • This is Genta’s 1st transaction in the Life Science sector.
  • This is Genta’s 1st transaction in the United States.
  • This is Genta’s 1st transaction in Utah.

M&A Deal Summary
Date 2003-08-25
Target Salus Therapeutics
Sector Life Science
Buyer(s) Genta
Deal Type Add-on Acquisition

Target

Salus Therapeutics

Salt Lake City, Utah, United States
Salus Therapeutics, Inc. engages in the identification and development of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA).

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Genta

Berkeley Heights, New Jersey, United States
Category Company
Founded 1988
Sector Life Science
Employees21
DESCRIPTION

Genta Inc. is a biopharmaceutical company exclusively focused on the development of novel therapies for cancer. Genta is a world leader in antisense research, having devoted considerable resources to the development of its proprietary Anticode (antisense) products.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Utah M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2003 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal